Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.
Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe website has added new features while removing extensive details related to participant groups, interventions, and various data fields available for download.SummaryDifference4%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
- Check36 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check43 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
- Check65 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check72 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.SummaryDifference1.0%
Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.